Icon
+91 94997 68112
Login Register

Tikosyn - (0.125,0.25,0.5 mg; Capsule, Oral)

Dofetilide Pfizer
0.125,0.25,0.5 mg; Capsule, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
More Than 5
More Than 5
Indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm
Yes
***** (*****) *** *** ***** ** **** **** ** **** ****** '*** (*** *, ****) *** *** ************ *********. ******* *** ********** *** ******* **** ***** ********* ** *** ***** ** ***** ***** ******** *** ******* ** **** ****. ******(********) ** *********** ********** *** ****** ** ** ** ********** **** ********* *** *** ********** ****. ** ******* ******* ******* ***** * **** ** **** *** **** ****** *** *** *** *********. ******* ***** * *********** ********* *** ***-************ ***** *** ********** *** ********* *** *******(******* **** ******) ******** *** ******* ** ***** **** . ************ *** **** **** ** **** '*** ****** *** *** ********* ******* ********** *** ********* **** *** ** *** ********* *** **** ** ** **** *** **** *** ****** ****** *** ******* **** *** *, ****. ********* **** ***** **** ** ***** ********** *** ********* **** ********* ********* ** ***** ********* *** ****** *** ******* ******* **** ********. ***** ****** **** ******** *** ******* ** ** ********** ** **** **** *** **** *** ********* **** * **** ****** *** **** *** ******** *** **** ** **** ****. *** **** ********* *** * ***** *** *******.
  1. *** **, **** : ****** ****** * **** ******* ***** (***** ******) ** ***** ***** **** ** **** ******* '*** (*** *, ****).
  2. *** **, **** : ****** *** ***** ******* * ********** ********* ********* ** *** ***** ** ***** ***** (***** ******) ******** *** ******* ** **** ****.
  3. *** *, **** : ***** ******** *** ******* **** *** **** ***********.
  4. *** **, **** : ******* ***** * **** ** **** ****** '*** (*** *, ****) *** *** *** ********* ** ****** ****** ** ****.
  5. *** **, **** : ******* ***** * *********** ********* ******* ***-************ ** ****** '***.
  6. *** **, **** : ********** *** ********* **** ******* ***** *** ***** ** ********* *** *** ***** *** ******* ******** *** ******* *.* ***** ***** *********.
  7. *** **, **** : *** ******** ****** ********* **** ** ****** **** '*** (*** *, ****) ** ******.
  8. *** **, **** : ****** **** *** ** ** ** ********.
  9. *** **, **** : ********** ********* **** *** ** *** ********* *** **** ** ** **** ***.
  10. *** *, **** : ****** ***** * **** ******* ********* ** ********* ***** **** ** **** ****** '*** (*** *, ****) ** ******.
  11. *** **, **** : **** ****** (*******) ******** *** *******.
  12. *** **, **** : ***** ****** ******** *** ******* ******** ***** ** ** ****** ** *** **** ** ********** **** ***** ******.
  13. *** **, **** : ********** ********* **** ********* ** ****** ******* * ******** *** ** *** ** ********* *** ****** '*** '*** (*** *, ****) ** ******.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.